)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Cereno Scientific (CRNO) investor relations material
Cereno Scientific Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary27 Nov, 2025
Executive summary
Advanced clinical pipeline with three drug candidates targeting rare cardiovascular and pulmonary diseases, focusing on disease-modifying therapies with high unmet needs.
Lead candidate CS1 is progressing toward a global Phase IIb trial for pulmonary arterial hypertension (PAH) after successful Phase IIa results and regulatory alignment with the FDA.
CS014, a novel HDAC inhibitor, completed a positive Phase I trial, demonstrating safety and supporting advancement to Phase II for idiopathic pulmonary fibrosis (IPF).
CS585, a selective IP receptor agonist, continues preclinical development, showing potential for thrombosis prevention without increased bleeding risk.
Financial highlights
Net sales for Q3 2025 were SEK 12.4 million, down from SEK 23.8 million in Q3 2024.
Operating loss for Q3 2025 was SEK -13.5 million, compared to SEK -15.3 million in Q3 2024.
Loss after financial items for Q3 2025 was SEK -21.3 million, slightly improved from SEK -22.7 million in Q3 2024.
Cash and bank balances at quarter-end were SEK 74.2 million.
Equity/assets ratio decreased to 49.5% from 66.8% year-over-year.
Outlook and guidance
Anticipates FDA clearance to proceed with the Phase IIb CS1 trial in H1 2026.
Plans to initiate Phase II development for CS014 in IPF, leveraging strong Phase I and preclinical data.
Continued focus on advancing the pipeline and expanding scientific visibility through upcoming conferences and publications.
CS1 Phase IIb trial design rationale
CS014 Phase II development strategy
CS585 differentiation in thrombosis prevention
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cereno Scientific earnings date
Q4 202527 Feb, 2026
Next Cereno Scientific earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cereno Scientific is a biotechnology company developing epigenetic therapies for cardiovascular and rare diseases. The company focuses on compounds that modulate endogenous defense mechanisms, with applications in thrombosis and inflammation. It operates in preclinical and clinical research stages. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the STO.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage